Asb Consultores, LLC Gilead Sciences, Inc. Transaction History

Asb Consultores, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $306,720 - $374,037	4,285 New	4,285 $313,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $152 - $173	2 Added 0.07%	2,992 $230,000
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $231,156 - $263,359	2,990 New	2,990 $248,000
Q3 2022 Jan 11, 2023	SELL	$59.54 - $68.01 $193,921 - $221,508	-3,257 Closed	0 $0
Q2 2022 Jan 11, 2023	BUY	$57.72 - $65.01 $187,994 - $211,737	3,257 New	3,257 $201,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

Stay updated on Asb Consultores, LLC with notifications on news.